Invicro

31 articles about Invicro

• Cell Stress and Mitochondrial Dysfunction Found in Early Alzheimer’s Disease Patients, Findings Published in Science Translational Medicine

  8/18/2022

  Invicro LLC (Invicro), a global, industry-leading imaging CRO, and a subsidiary of REALM IDx, Inc., today announced the publication of the paper “Widespread cell stress and mitochondrial dysfunction occur in patients with early Alzheimer’s disease 1” in Science Translational Medicine.

• Telix and Invicro Advance AI Partnership

  6/14/2022

  Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has advanced a partnership with Invicro LLC.

• Invicro, DTi, and NIH Bring Imaging and Genomics Data Together with Advanced Analytics to Help Improve Therapies in Dementia

  9/28/2021

  Invicro LLC announces a collaboration with the National Institutes of Health's new intramural research effort, the Center for Alzheimer's and Related Dementias, through a data science contract with Data Tecnica International LLC, to offer a curated collection of harmonized brain imaging and genomics data that will help identify dementia and other neurodegenerative disorder risk factors to better stratify subjects and their disease progression.

• Invicro LLC to Establish a Repository of Medical Image Datasets for COVID-19 Research

  5/5/2020

  Invicro LLC, a Konica Minolta company, is working with Microsoft to create a free repository of COVID-19 diagnostic CT and X-ray datasets to facilitate understanding and treating this global threat.

• 

  BioSpace Movers & Shakers, Dec. 27

  12/27/2019

  Pharma and life sciences companies bolster their leadership teams and boards with this week's Movers & Shakers.

• Invicro LLC Announces Dr. Matthew Silva as New Chief Executive Officer and Dr. Jack Hoppin is Named President of Konica Minolta Precision Medicine

  12/23/2019

  Invicro LLC, a Konica Minolta company, today announces, Dr. Matthew Silva has been appointed as the new Chief Executive Officer. Dr. Silva will assume the day-to-day leadership responsibilities of the Company and will join Invicro’s Board of Directors, effective immediately.

• Invicro Supports the Alzheimer’s Disease Neuroimaging Initiative

  12/11/2019

  Invicro LLC, a Konica Minolta Company, today announced funding support for the Alzheimer’s Disease Neuroimaging Initiative (ADNI), and two of their distinguished scientists within the Alzheimer’s biomarkers space, Drs. Roger Gunn and Kenneth Marek, will join the ADNI-Private Partner Scientific Board (PPSB).

• Invicro LLC Joins Accenture’s INTIENT™ Network to Help Advance Innovation in Drug Discovery and Scientific Research

  12/3/2019

  Invicro is a global provider of imaging biomarkers, core lab services, advanced analytics and software solutions for drug discovery and development.

• Invicro’s Software Leadership Team Expands with Two New Executives

  11/20/2019

  Invicro LLC, a Konica Minolta Company, announced the expansion of their Software leadership team with the hiring of Mr. Chris Fuller, Vice President of Software and Mr. Timothy Moran as Senior Director of Product Management.

• Invicro Appoints Dr. Evan Morris as Vice President of Scientific Imaging Research, New Haven

  9/16/2019

  Evan Morris, Ph.D. as VP of Scientific Imaging Research, New Haven.

• Invicro Scientists Published in Science Translational Medicine

  9/4/2019

  Invicro LLC, a Konica Minolta company and a leading provider of imaging biomarkers, core lab services and software for research and drug development, announces that the paper “In vivo Detection of Cerebral Tau Pathology in Long-term Survivors of Traumatic Brain Injury1” has been published in Science Translational Medicine.

• Invicro Names Mr. Hidenori Seshimo as Vice President of Biomarker Services, Japan

  8/29/2019

  Invicro is a Konica Minolta company and a leading provider of imaging biomarkers, core lab services and software for research and drug development

• Invicro and iThera Medical Announce a Strategic Partnership to Enhance in vivo Imaging Capabilities with the MSOT inVision Optoacoustic Imaging Platform

  4/30/2019

  Invicro LLC, a Konica Minolta company and iTheraMedical GmbH announced a unique partnership with the placement of the MSOT inVision platform in Invicro’s in vivo laboratory out of its Boston headquarters.

• Invicro and icometrix Announce a Unique Partnership to Provide an Automated Workflow for Imaging Core Lab Services and Advanced Informatics to Pharmaceutical and Biotechnology Sponsors Worldwide.

  3/4/2019

  Invicro LLC, a Konica Minolta company and icometrix jointly announced a partnership that will seamlessly offer the world’s most comprehensive breadth of imaging core lab services combined with the most robust FDA-cleared MRI informatics capabilities through automated workflows.

• Invicro Appoints Dr. Joseph Krueger as Vice President, Research and Applications for Advanced Pathology Services

  2/14/2019

  Invicro is a Konica Minolta company and a leading provider of imaging services and software for research and drug developmen

• Enigma Biomedical and Invicro Sign a Memorandum of Understanding to Co-Develop Synaptic Density Biomarker Imaging

  9/21/2018

  Enigma Biomedical Group (EBG) today announced a collaboration agreement with Invicro, a Konica Minolta Company and a leading provider of imaging services and software for research and drug development, to cooperate in the development of Synaptic Density Biomarker Imaging (“SDI”).

• Enigma Biomedical Group and Invicro Sign a Collaboration Agreement

  8/20/2018

  Enigma Biomedical Group (EBG) today announced a collaboration agreement with Invicro

• Invicro Names Dr. Brian Avants as Senior Director of Machine Learning

  8/2/2018

  Invicro LLC is a Konica Minolta company and a leading provider of imaging services and software for research and drug development

• Invicro Scientists Awarded Alavi-Mandell Publication Award and Named Finalist for the Ziskind-Somerfeld Research Award

  7/19/2018

  Invicro LLC announces that a study conducted at Invicro London (formerly Imanova) has been awarded the Alavi-Mandell Publication Award by the Journal of Nuclear Medicine (JNM) for the publication entitled, “11C-PBR28 or 18F-PBR111 detect white matter inflammatory heterogeneity in multiple sclerosis”.

• Invicro and Ambry Genetics Appoint Dr. Kenneth Bloom as Chief Medical Officer of Advanced Pathology and Genomic Services

  6/20/2018

  Precision medicine companies and leading providers of quantitative biomarker and genomic profiling services